Views

Read op-eds and interviews from our staff, allies and partners.

Disengagement in HIV care

Last updated:

James Cole, our Senior Policy, Research and Influencing Manager, write about how disengagement in HIV care is a global issue driven by inequalities and intersecting forms of stigma and discrimination.

HIV Action Plan: towards 2030 and living well with HIV

Last updated:

Robbie Currie, our Chief Executive Officer, writes that we have a once in a generation opportunity to end the five-decade long struggle against HIV. But we’ll only get there if the Government publishes an ambitious new HIV Action Plan.

What next for the HIV response in the UK?

Last updated:

Daniel Fluskey, our Director of Policy, Research and Influencing, writes about how ensuring high quality, equitable, and sustainable HIV and sexual health services across the UK has to be the bedrock of public policy that aims to end HIV transmissions and support everyone to live well with HIV.

Positive Voices: step change in HIV action needed

Last updated:

Daniel Fluskey, our Director of Policy, Research and Influencing, on the Positive Voices report - the largest survey of people living with HIV - and how it must provoke significant change in HIV action.

BHIVA Spring Conference 2023: PrEP, testing, quality of life

Last updated:

Adam Freedman, our Policy, Research and Influencing Manager, write how the BHIVA Spring Conference was a chance to learn about the latest developments in HIV medicine and healthcare. A running theme was the shared desire to improve the experiences of people living with, or at risk of acquiring, HIV within the healthcare system.

The unique challenges for women living with HIV

Last updated:

Originally from Kenya, and a National AIDS Trust trustee, Angelina is experienced in providing one-to-one support, treatment advocacy, managing service delivery, and advocating for the involvement of women living with HIV in strategy and policy.

Long-acting injectables: Dr Tristan Barber Q&A

Last updated:

Dr Tristan Barber writes how last month, NICE approved the use of long-lasting injectable treatment for people living with HIV, the first alternative to daily oral pills. You can read our full blog on the announcement here.